v3.19.2
Stockholders' Deficit (Details 2) - Series RX-3 Preferred Stock Warrant [Member]
6 Months Ended
Jun. 30, 2019
USD ($)
shares
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 1,397,647
Total Number of RX- 3 Shares For Which Warrants Issued Are Exercisable 481,212
Controller [Member]  
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 235,775
Total Number of RX- 3 Shares For Which Warrants Issued Are Exercisable 81,806
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 81,806,000
President and chief executive officer [Member]  
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 609,716
Total Number of RX- 3 Shares For Which Warrants Issued Are Exercisable 211,733
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 211,733,000
General Counsel [Member]  
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 552,156
Total Number of RX- 3 Shares For Which Warrants Issued Are Exercisable 187,673
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 187,673,000
Preferred Stock Warrant One [Member]  
Aggregate Principal and Interest Consideration Exchanged/Paid | $ $ 1,397,647
Total Number of RX- 3 Shares For Which Warrants Issued Are Exercisable 481,212
Total Number of Common Shares Into Which Shares are Convertible (Before Any Potential Adjustment) 481,212,000